MEDICAMEN BIOTECH
Back to Cashflow Statement
|
MEDICAMEN BIOTECH Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-1.47 Cr | ₹6.31 Cr | ₹29 Cr | ₹4.30 Cr | ₹5.84 Cr |
What is the latest Cash Flow from Financing Activities ratio of MEDICAMEN BIOTECH ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-1.47 Cr |
| Mar2024 | ₹6.31 Cr |
| Mar2023 | ₹29 Cr |
| Mar2022 | ₹4.30 Cr |
| Mar2021 | ₹5.84 Cr |
How is Cash Flow from Financing Activities of MEDICAMEN BIOTECH Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1.47 Cr | Negative | |
| Mar2024 | ₹6.31 Cr | -78.32 | |
| Mar2023 | ₹29 Cr | 577.69 | |
| Mar2022 | ₹4.30 Cr | -26.39 | |
| Mar2021 | ₹5.84 Cr | - | |
Compare Cash Flow from Financing Activities of peers of MEDICAMEN BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MEDICAMEN BIOTECH | ₹545.4 Cr | 0.7% | 9.2% | -10.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,370.0 Cr | 1.2% | 5.5% | 0.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,802.0 Cr | -1.8% | -3.1% | 8.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,841.0 Cr | -2% | 2.8% | 19.2% | Stock Analytics | |
| CIPLA | ₹121,481.0 Cr | -0.7% | -8.6% | 2.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,220.0 Cr | -1.5% | -4.3% | 2.5% | Stock Analytics | |
MEDICAMEN BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MEDICAMEN BIOTECH | 0.7% |
9.2% |
-10.7% |
| SENSEX | -0.1% |
0.6% |
9.8% |
You may also like the below Video Courses